Company intelligence / Profile preview

Jianmin Pharmaceutical Group

Wuhan, Hubei, China

Ownership: Private
Employees: ~2345
Development stage: Other

Overview

Commercial-stage pharmaceutical company with approved OTC and prescription products focused on pediatrics and chronic diseases, reporting revenue growth in manufacturing segment despite overall revenue decline in H1 2025.

Therapeutic areas: Women's HealthPulmonologyOtherGastroenterology
Modalities: Small moleculeHerbal medicine
Industry: Biotech

Beyond the preview

Go deeper on Jianmin Pharmaceutical Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jianmin Pharmaceutical Group.

Explore the full profile